Mark O. Collins
AstraZeneca (Finland)(FI)AstraZeneca (Sweden)(SE)University of Sheffield(GB)
Publications by Year
Research Areas
Advanced Proteomics Techniques and Applications, Cellular transport and secretion, Neuroscience and Neuropharmacology Research, Mass Spectrometry Techniques and Applications, Receptor Mechanisms and Signaling
Most-Cited Works
- → A polygenic burden of rare disruptive mutations in schizophrenia(2014)1,439 cited
- → De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia(2011)871 cited
- → Characterization of the proteome, diseases and evolution of the human postsynaptic density(2010)521 cited
- → Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome(2005)444 cited
- → Proteomic Analysis of in Vivo Phosphorylated Synaptic Proteins(2004)325 cited
- → TBK1: a new player in ALS linking autophagy and neuroinflammation(2017)317 cited
- → Targeted tandem affinity purification of PSD‐95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins